Association of sex hormone-binding globulin and free testosterone with mortality in men with type 2 diabetes mellitus

European Journal of Endocrinology

Volumn 174, Issue 1, 2016, Pages 59-68

  Tint, Aye N ^a   Hoermann, Rudolf ^b   Wong, Henry ^a   Ekinci, Elif I ^a,b   MacIsaac, Richard J ^b,c   Jerums, George ^a,b   Zajac, Jeffrey D ^a,b   Grossmann, Mathis ^a,b  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY MASS; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FOLLOW UP; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TERTIARY CARE CENTER; VASCULAR DISEASE; BLOOD; CARDIOVASCULAR DISEASE; MIDDLE AGED; NEOPLASM; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 84956719145     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0672     Document Type: Article

References (29)

1. RosnerW, Hryb DJ, Kahn SM, Nakhla AM & Romas NA. Interactions of sex hormone-binding globulin with target cells. Molecular and Cellular Endocrinology 2010 316 79-85. (doi:10.1016/j.mce.2009.08.009)
2. Hammes A, Andreassen TK, Spoelgen R, Raila J, Hubner N, Schulz H, Metzger J, Schweigert FJ, Luppa PB, Nykjaer A et al. Role of endocytosis in cellular uptake of sex steroids. Cell 2005 122 751-762. (doi:10.1016/j. cell.2005.06.032)
3. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM & Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. New England Journal of Medicine 2009 361 1152-1163. (doi:10.1056/NEJMoa0804381)
4. Bhasin S, Jasjua GK, Pencina M, D'Agostino R S, Coviello AD, Vasan RS & Travison TG. Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: The framingham heart study. Diabetes Care 2011 34 2464-2470. (doi:10.2337/dc11-0888)
5. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS & Montori VM. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2010 95 2536-2559. (doi:10.1210/jc.2009-2354)
6. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT & Wittert GA. Clinical review: Endogenous testosterone and mortality in men: A systematic review and meta-Analysis. Journal of Clinical Endocrinology and Metabolism 2011 96 3007-3019. (doi:10.1210/jc.2011-1137)
7. Muraleedharan V, Marsh H, Kapoor D, Channer KS & Jones TH. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. European Journal of Endocrinology 2013 169 25-733. (doi:10.1530/EJE-13-0321)
8. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A & Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2004 89 5462-5468. (doi:10.1210/jc.2004-0804)
9. Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD & Jerums G. Low testosterone levels are common and associated with insulin resistance in men with diabetes. Journal of Clinical Endocrinology and Metabolism 2008 93 1834-1840. (doi:10.1210/ jc.2007-2177)
10. Sikaris K, McLachlan RI, Kazlauskas R, de Kretser D, Holden CA & Handelsman DJ. Reproductive hormone reference intervals for healthy fertile young men: Evaluation of automated platform assays. Journal of Clinical Endocrinology and Metabolism 2005 90 5928-5936. (doi:10.1210/ jc.2005-0962)
11. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 3666-3672. (doi:10.1210/jcem.84.10.6079)
12. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing,Vienna, Austria. 2015 http://wwwR-projectorg/.
13. Fellows I. Deducer: A data analysis GUI for R. Journal of Statistical Software 2012 49 1-15. (doi:10.18637/jss.v049.i08)
14. Henning PC, Scofield DE, Spiering BA, Staab JS, Matheny RW Jr, Smith MA, Bhasin S & Nindl BC. Recovery of endocrine and inflammatory mediators following an extended energy deficit. Journal of Clinical Endocrinology and Metabolism 2014 99 956-964.
15. Kalyani RR, Gavini S & Dobs AS. Male hypogonadism in systemic disease. Endocrinology and Metabolism Clinics of North America 2007 36 333-348. (doi:10.1016/j.ecl.2007.03.014)
16. Damassa DA, Lin TM, Sonnenschein C & Soto AM. Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells. Endocrinology 1991 129 75-84. (doi:10.1210/endo-129-1-75)
17. Hryb DJ, Khan MS, Romas NA & Rosner W. The control of the interaction of sex hormone-binding globulin with its receptor by steroid hormones. Journal of Biological Chemistry 1990 265 6048-6054.
18. Kalme T, Seppala M, Qiao Q, Koistinen R, Nissinen A, Harrela M, Loukovaara M, Leinonen P & Tuomilehto J. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. Journal of Clinical Endocrinology and Metabolism 2005 90 1550-1556. (doi:10.1210/jc.2004-0762)
19. Goodman-Gruen D & Barrett-Connor E. A prospective study of sex hormone-binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women. Journal of Clinical Endocrinology and Metabolism 1996 81 2999-3003.
20. Araujo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ & McKinlay JB. Sex steroids and all-cause and cause-specific mortality in men. Archives of Internal Medicine 2007 167 1252-1260. (doi:10.1001/ archinte.167.12.1252)
21. Hyde Z, Norman PE, Flicker L, Hankey GJ, Almeida OP, McCaul KA, Chubb SA & Yeap BB. Low free testosterone predicts mortality from cardiovascular disease but not other causes: The Health in Men Study. Journal of Clinical Endocrinology and Metabolism 2012 97 179-189. (doi:10.1210/jc.2011-1617)
22. Pascual-Figal DA, Tornel PL, Nicolas F, Sanchez-Mas J, Martinez MD, Gracia MR, Garrido IP, Ruiperez JA & Valdes M. Sex hormone-binding globulin: A new marker of disease severity and prognosis in men with chronic heart failure. Revista Española de Cardiología 2009 62 1381-1387.
23. Svartberg J, Schirmer H, Wilsgaard T, Mathiesen EB, Njolstad I, Lochen ML & Jorde R. Single-nucleotide polymorphism, rs1799941 in the Sex Hormone-Binding Globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2 diabetes, cancer and mortality in men: The Tromso Study. Andrology 2014 2 212-218. (doi:10.1111/j.2047-2927.2013. 00174.x)
24. Khaw KT & Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Annals of Epidemiology 1992 2 675-682. (doi:10.1016/1047-2797(92)90012-F)
25. Rosner W, Auchus RJ, Azziz R, Sluss PM & Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: An Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism 2007 92 405-413. (doi:10.1210/jc.2006-1864)
26. Gianatti EJ, Dupuis P, Hoermann R, Strauss BJ, Wentworth JM, Zajac JD & Grossmann M. Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: A randomized controlled trial. Diabetes Care 2014 37 2098-2107. (doi:10.2337/dc13-2845)
27. Harwood DT & Handelsman DJ. Development and validation of a sensitive liquid chromatography-Tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clinica Chimica Acta 2009 409 78-84. (doi:10.1016/j. cca.2009.09.003)
28. RosnerW. Sex steroids and the free hormone hypothesis. Cell 2006 124 455-456; author reply 456-457. (doi:10.1016/j.cell.2006.01.026)
29. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A et al. Adverse events associated with testosterone administration. New England Journal of Medicine 2010 363 109-122. (doi:10.1056/NEJMoa1000485)